Each week, we highlight recent news, stories, and updates from across the Cortado Ventures portfolio. From product advancements to industry recognition, these updates reflect the continued growth and impact our companies are driving across critical industries.

Subscribe to the Doubleshot Newsletter for more updates. Follow us on LinkedIn, Medium, and Instagram to stay connected.

This Week In the Portfolio – 06/01-06/05

CorriXR Therapeutics – June 2

CorriXR Therapeutics was featured by Delaware Business Times as one of the bioscience companies helping shape the future of medicine. The recognition highlights CorriXR’s work developing therapies for difficult-to-treat squamous cell cancers by targeting the biological mechanisms that enable tumor survival and treatment resistance.

Read more here.

Apricot Health – June 4

Apricot Health announced it is expanding beyond Start of Care documentation to support the entire home health episode of care, including OASIS assessments, routine visits, coding support, and validation workflows. The company highlighted its continued focus on building trusted AI solutions that solve complex documentation challenges while maintaining quality and compliance.

Ready more here.

Equipt AI – June 4

Dr. (Hon) Amarpal Nanda, Co-Founder & COO of Equipt AI, was named a Houston Business Journal 2026 40 Under 40 honoree. The award recognizes his leadership, innovation, and contributions to advancing technology and business impact within the Houston community.

Read more here.

**

Cortado Ventures is an early-stage venture capital firm that invests in ambitious, growth-driven companies, backing a new generation of economic prosperity for the Midcontinent region, defined as Oklahoma, Texas, Arkansas, Missouri, Colorado, Kansas and New Mexico. As one of the largest VC funds in Oklahoma, Cortado’s focus is on tech companies bringing innovative solutions to the frontier, space, energy and logistics, life sciences, and the future of work sectors.

For more information, visit cortado.ventures.

Support MidconVC by clicking HERE.